{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:39:10Z","timestamp":1786358350528,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clinthera.2010.04.014","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T04:57:25Z","timestamp":1272603445000},"page":"615-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Roeland","family":"Huijgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evertine J.","family":"Abbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton F.H.","family":"Stalenhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben P.M.","family":"Imholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Durrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Trip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen R.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.04.014_bib1","series-title":"The Metabolic & Molecular Bases of Inherited Disease","author":"Scriver","year":"2001"},{"key":"10.1016\/j.clinthera.2010.04.014_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14779072.6.4.567","article-title":"Familial hypercholesterolemia: Current treatment and advances in management","volume":"6","author":"Huijgen","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.clinthera.2010.04.014_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2796.2003.01070.x","article-title":"Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia","volume":"253","author":"de Sauvage Nolting","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2010.04.014_bib4","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: A long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2010.04.014_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2010.04.014_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1503\/cmaj.051313","article-title":"Heterozygous familial hypercholesterolemia: An underrecognized cause of early cardiovascular disease","volume":"174","author":"Yuan","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2010.04.014_bib7","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2010.04.014_bib8","doi-asserted-by":"crossref","first-page":"a1095","DOI":"10.1136\/bmj.a1095","article-title":"Familial hypercholesterolaemia: Summary of NICE guidance","volume":"337","author":"Wierzbicki","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2010.04.014_bib9","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: Executive summary","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2010.04.014_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2010.04.014_bib11","first-page":"18","article-title":"The practice guideline \u2018Diagnosis and treatment of familial hypercholesterolaemia\u2019 of the Dutch Health Care Insurance Board [in Dutch]","volume":"150","author":"Walma","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.clinthera.2010.04.014_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1258\/acb.2007.007078","article-title":"Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project","volume":"45","author":"Hadfield","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clinthera.2010.04.014_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2010.04.014_bib14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1001\/archinte.159.16.1893","article-title":"Colesevelam hydrochloride (cholestagel): A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects","volume":"159","author":"Davidson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2010.04.014_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1185\/030079908X280446","article-title":"Colesevelam hydrochloride in clinical practice: A new approach in the treatment of hypercholesterolaemia","volume":"24","author":"Florentin","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2010.04.014_bib16","doi-asserted-by":"crossref","first-page":"47C","DOI":"10.1016\/j.amjcard.2006.11.022","article-title":"Safety considerations with gastrointestinally active lipid-lowering drugs","volume":"99","author":"Jacobson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2010.04.014_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00129784-200707060-00009","article-title":"Colesevelam: A review of its use in hypercholesterolemia","volume":"7","author":"Robinson","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.clinthera.2010.04.014_bib18","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/eurheartj\/ehl113","article-title":"Diagnosing familial hypercholesterolaemia: The relevance of genetic testing","volume":"27","author":"van Aalst-Cohen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2010.04.014_bib19","first-page":"325","article-title":"Evaluation of a commercial kit for the determination of LDL-cholesterol in serum based on precipitation of LDL with Dextran Sulfate","author":"Armstrong","year":"1985","journal-title":"Aerztl Lab"},{"key":"10.1016\/j.clinthera.2010.04.014_bib20","first-page":"1127","article-title":"Long-term stable liquid ready-to-use monoreagent for the enzymatic assay of serum or plasma triglycerides (GPO-PAP method)","volume":"39","author":"Siedel","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2010.04.014_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/clinchem\/41.5.717","article-title":"Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alphacyclodextrin","volume":"41","author":"Sugiuchi","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2010.04.014_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinchem\/29.6.1075","article-title":"Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency","volume":"29","author":"Siedel","year":"1983","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2010.04.014_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/32.6.957","article-title":"Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum","volume":"32","author":"Rifai","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2010.04.014_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9343(01)00638-6","article-title":"Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia","volume":"110","author":"Knapp","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2010.04.014_bib25","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1185\/030079906X148436","article-title":"Lipid-lowering effects of colesevelam HCl in combination with ezetimibe","volume":"22","author":"Bays","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2010.04.014_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(01)00437-3","article-title":"Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively","volume":"158","author":"Hunninghake","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2010.04.014_bib27","series-title":"Common Statistical Methods for Clinical Research","article-title":"Analysis of covariance","author":"Walker","year":"2002"},{"key":"10.1016\/j.clinthera.2010.04.014_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2010.04.014_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00392-006-0403-x","article-title":"Low density lipoprotein cholesterol, statins and cardiovascular events: A meta-analysis [published correction appears in Clin Res Cardiol. 2007;96:526]","volume":"95","author":"Genser","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.clinthera.2010.04.014_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.clinthera.2007.05.012","article-title":"Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials","volume":"29","author":"Gould","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2010.04.014_bib31","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2005.05.085","article-title":"Pleiotropic effects of statins: Benefit beyond cholesterol reduction? A meta-regression analysis","volume":"46","author":"Robinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2010.04.014_bib32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)","volume":"323","author":"Buchwald","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2010.04.014_bib33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1503\/cmaj.070675","article-title":"The efficacy and safety of intensive statin therapy: A meta-analysis of randomized trials","volume":"178","author":"Josan","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2010.04.014_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, doubleblind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2010.04.014_bib35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia [published correction appears in N Engl J Med. 2008;358:1977]","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2010.04.014_bib36","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","article-title":"Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment","volume":"117","author":"Kastelein","year":"2008","journal-title":"Circulation"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:17Z","timestamp":1758962897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0149291810001384"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}